Stock Events

Stock Events

Kaken Pharmaceutical (4521.TSE) Q4 2025 Earnings

10NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-139

-51

36

124

Details

Expected EPS

N/A

Actual EPS

20

Surprise EPS

20

Surprise Percent

+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 20 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.